ProBioGen AG, a renowned Contract Development and Manufacturing Organization (CDMO), offers a top-tier cell line development service for biologics through their innovative CHO.RiGHT platform. Leveraging DirectedLuck transposase and transposons, along with optimized CHO host cells and chemically defined process media, ProBioGen ensures high genetic stability and efficient metabolism in their CHO-DG44 strain.
With a focus on tailored bioassays, ProBioGen guarantees precise testing of biopharmaceutical potency and stability to meet rigorous regulatory standards and streamline clinical development. Their comprehensive bioassay services cover a range of maturation levels, from lab methods to GMP-batch release testing, providing flexibility and expertise at every stage of biopharmaceutical development. Partnering with ProBioGen means access to cutting-edge technologies like GlymaxX for producing specialized antibodies. Elevate your biopharmaceutical development with ProBioGen’s unparalleled expertise and advanced bioassay solutions.
Tags: cell line development
Read more from probiogen.de